Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 954–964.

    Article  Google Scholar 

  2. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.

    Article  CAS  Google Scholar 

  3. Sorror ML, Storer B, Storb RF . Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences. Biol Blood Marrow Transplant 2009; 15: 757–758.

    Article  Google Scholar 

  4. Raimondi R, Tosetto A, Oneto R, Cavazzina R, Rodeghiero F, Bacigalupo A et al. Validation of the hematopoietic cell transplantation-specific comorbidity Index: a prospective, multicenter GITMO study. Blood 2012; 120: 1327–1333.

    Article  CAS  Google Scholar 

  5. Le RQ, Bevans M, Savani BN, Mitchell SA, Stringaris K, Koklanaris E et al. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2010; 16: 1162–1170.

    Article  CAS  Google Scholar 

  6. Le RQ, Melenhorst JJ, Battiwalla M, Hill B, Memon S, Savani BN et al. Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation. Blood 2011; 117: 5250–5256.

    Article  CAS  Google Scholar 

  7. Gratwohl A . The EBMT risk score. Bone Marrow Transplant 2012; 47: 749–756.

    Article  CAS  Google Scholar 

  8. Lodewyck T, Oudshoorn M, van der Holt B, Petersen E, Spierings E . von dem Borne PA et al. Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia. Leukemia 2011; 25: 1548–1554.

    Article  CAS  Google Scholar 

  9. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2012; 97: 262–269.

    Article  Google Scholar 

  10. Thoma MD, Huneke TJ, DeCook LJ, Johnson ND, Wiegand RA, Litzow MR et al. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2012; 18: 600–607.

    Article  Google Scholar 

  11. Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ et al. Day 100 peripheral blood absolute lymphocyte/monocyte ratio and survival in classical Hodgkin's lymphoma postautologous peripheral blood hematopoietic stem cell transplantation. Bone Marrow Res 2013; 2013: 658371.

    Article  Google Scholar 

  12. Breiman L, Friedman JH, Olshen RA, Stone CJ . Classification and Regression Trees. Wadsworth International Group: : Belmont, CA, USA, 1984.

    Google Scholar 

  13. Pencina MJ, D’Agostino RB Sr, Steyerberg EW . Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11–21.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the Intramural Research Program of the NHLBI, NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Battiwalla.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le, R., Tian, X., Jain, N. et al. Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50, 1138–1140 (2015). https://doi.org/10.1038/bmt.2015.112

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.112

Search

Quick links